The global neuroendocrine tumours treatment market was valued at USD 2.45 Billion in 2024 and is projected to reach USD 5.40 Billion by 2034, growing at a CAGR of 8.23%. This growth is driven by increasing incidence rates and ongoing advancements in treatment modalities across major global markets. https://www.expertmarketresearch.com/reports/neuroendocrine-tumours-treatment-market